Variantyx (Series C)
Funding Details
Awarder
Inbox
Date Award
March 15, 2021
Vertical
Genomics
Funding Amount
$20,000,000
Company Info
Founders
Haim Neerman
Market
Healthcare
Location
Framingham, MA, USA
Coinvestors
20/20 HealthCare Partners, GHS Fund, IBM Ventures, New Era Capital Partners, Pitango Venture Capital, Zander Lurie
Company Description

Variantyx is a CLIA/CAP laboratory providing Genomic Unity, a whole genome sequencing (WGS)-based testing program for diagnosis of rare inherited disorders. Its single method approach to comprehensive genetic testing identifies multiple variant types within a single patient sample to provide a unified clinical report.

Links